Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Tempus AI, Inc. secures up to $9.5 million in funding from ARPA-H to develop the first autonomous clinical AI agent for cardiology. This funding will help advance AI applications for patients with heart failure.
Sep 10, 2026•about 4 hours ago
ChicagoOtherBiotechnologyDescription
Tempus AI, Inc. announced it has been awarded up to $9.5 million by ARPA-H to develop an autonomous clinical AI agent. This project aims to enhance care for patients suffering from heart failure. The funding is part of ARPA-H's ADVOCATE initiative
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months
Tempus AI signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.